Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 233.00 | 200.75 | 1.1606 | 1.1976 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 228.00 | 200.75 | 1.1357 | 1.1677 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 274.00 | 200.75 | 1.3649 | 1.4348 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 156.25 | 67.09 | 312.00 | 200.75 | 1.5542 | 1.6433 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 192.00 | 200.75 | 0.9564 | 0.9444 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 188.00 | 200.75 | 0.9365 | 0.9187 | |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 162.00 | 200.75 | 0.8070 | 0.7463 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 156.25 | 67.09 | 184.00 | 200.75 | 0.9166 | 0.8928 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 356.00 | 200.75 | 1.7733 | 1.8733 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 67.09 | 224.00 | 200.75 | 1.1158 | 1.1435 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 156.25 | 67.09 | 127.00 | 200.75 | 0.6326 | 0.4972 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 156.25 | 67.09 | 226.00 | 200.75 | 1.1258 | 1.1556 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 156.25 | 67.09 | 268.00 | 200.75 | 1.3350 | 1.4010 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 179.00 | 200.75 | 0.8917 | 0.8601 | |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 161.00 | 200.75 | 0.8020 | 0.7395 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 156.25 | 67.09 | 314.00 | 200.75 | 1.5641 | 1.6540 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 258.00 | 200.75 | 1.2852 | 1.3439 | |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 156.25 | 67.09 | 211.00 | 200.75 | 1.0511 | 1.0640 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 156.25 | 67.09 | 158.00 | 200.75 | 0.7871 | 0.7189 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 156.25 | 67.09 | 146.00 | 200.75 | 0.7273 | 0.6352 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 69.00 | 200.75 | 0.3437 | 0.0179 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 237.00 | 200.75 | 1.1806 | 1.2214 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 273.00 | 200.75 | 1.3599 | 1.4292 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 156.25 | 67.09 | 183.00 | 200.75 | 0.9116 | 0.8863 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 156.25 | 67.09 | 235.00 | 200.75 | 1.1706 | 1.2095 |